NCT03924206

Brief Summary

The investigators will define two separate groups of surgical procedures: 1.) an 'open group' in which mainly open anatomic lung resections will be included, and 2.) a 'minimally invasive' group in which mainly thoracoscopic anatomic lung resections will be included. Both groups will then be randomized to either the performance of the surgical procedure under 'standard conditions' or to the performance of the procedure with the additional use of a smoke evacuation system. During every procedure the hazardous smoke that is generated by the electrocautery in the surgical field will be collected through a tube at the height of the surgeons face. The smoke is then directly transferred to a mass spectrometer that is situated in the operating room (OR) and performs a real-time analysis of the chemical substances in the air. The degree of air pollution will be measured as well as the smoke evacuation systems' ability to reduce these hazardous chemical substances in the air can be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 23, 2019

Completed
20 days until next milestone

Study Start

First participant enrolled

May 13, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2019

Completed
Last Updated

October 3, 2019

Status Verified

October 1, 2019

Enrollment Period

4 months

First QC Date

April 9, 2019

Last Update Submit

October 2, 2019

Conditions

Keywords

SmokePlumeElectrocauteryMass spectrometer

Outcome Measures

Primary Outcomes (1)

  • Hazardous fumes - specifically the concentration of Furfural, Benzene and Butadiene

    Analysis of surgical fume with real-time time of flight mass spectrometry

    assessment of measurement will start 4 months after the project is started and will take up to 12 weeks

Study Arms (4)

Minimally invasive surgery with smoke evacuation system (SES)

minimally invasive surgical procedures during which a smoke evacuation device is used

Device: Smoke evacuation system

Minimally invasive surgery without SES

minimally invasive surgical procedures during which no smoke evacuation device is used

Open surgery with SES

open surgical procedures during which a smoke evacuation device is used

Device: Smoke evacuation system

Open surgery without SES

open surgical procedures during which no smoke evacuation device is used

Interventions

The smoke evacuation system removes the surgical smoke directly near the electrocautery tip, where it is generated

Minimally invasive surgery with smoke evacuation system (SES)Open surgery with SES

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All surgical procedures that will be performed during the study period at the investigators' department will be randomly allocated to either the performance of surgery with or the performance of surgery without the use of a mobile smoke evacuation device. Whether the procedure will be performed open or minimally invasive will be decided by the operating surgeon and is not part of the randomization process. During the respective surgeries, a mass spectrometer will be used to measure the smoke concentrations and its composition in the operating room.

You may qualify if:

  • \- All surgical procedures with a planned duration of more than 1 hour

You may not qualify if:

  • Patients with a contraindication for electrocautery use
  • Patients with Pacemaker or implantable cardioverter-defibrillator (ICD)
  • Patients with an implanted neurostimulator device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Bern

Bern, 3010, Switzerland

Location

Related Publications (2)

  • Kocher GJ, Sesia SB, Lopez-Hilfiker F, Schmid RA. Surgical smoke: still an underestimated health hazard in the operating theatre. Eur J Cardiothorac Surg. 2019 Apr 1;55(4):626-631. doi: 10.1093/ejcts/ezy356.

    PMID: 30388210BACKGROUND
  • Kocher GJ, Koss AR, Groessl M, Schefold JC, Luedi MM, Quapp C, Dorn P, Lutz J, Cappellin L, Hutterli M, Lopez-Hilfiker FD, Al-Hurani M, Sesia SB. Electrocautery smoke exposure and efficacy of smoke evacuation systems in minimally invasive and open surgery: a prospective randomized study. Sci Rep. 2022 Mar 23;12(1):4941. doi: 10.1038/s41598-022-08970-y.

MeSH Terms

Conditions

Lung NeoplasmsLung Injury

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesThoracic InjuriesWounds and Injuries

Study Officials

  • Gregor J Kocher, PD, MD

    Division of Thoracic Surgery, University Hospital Bern, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2019

First Posted

April 23, 2019

Study Start

May 13, 2019

Primary Completion

September 9, 2019

Study Completion

September 9, 2019

Last Updated

October 3, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations